STOCK TITAN

Robert Harrison sells SERA shares under 10b5-1 plan (SERA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SERA insider Robert Harrison reported multiple sales of Common Stock under Form 144. The filing lists sales on 03/11/2026 (716 shares, 1460.64), 03/09/2026 (3,360 shares, 6585.60), 02/24/2026 (2,000 shares, 4686.00), 01/27/2026 (2,000 shares, 5942.00), and 12/30/2025 (2,000 shares, 6002.60). Several sales are labeled as 10b5-1 Sales. The filing also lists 2,000 Restricted Stock Units dated 02/06/2024.

Positive

  • None.

Negative

  • None.

Insights

Multiple, largely pre-arranged sales by a single reporting person are disclosed.

The filing documents specific dispositions: 03/11/2026 (716 shares), 03/09/2026 (3,360 shares), and three earlier dispositions labeled as 10b5-1 Sales. Each row ties a share count to a dollar amount in the excerpt.

These entries are transactional disclosures under Form 144; the presence of 10b5-1 language indicates some sales were executed under a pre-arranged plan. Subsequent filings or Form 4s would show post-transaction holdings and complete context.

Routine insider dispositions are disclosed; no regulatory outcome or allegation is present.

The excerpt also records 2,000 Restricted Stock Units dated 02/06/2024 listed as issuer securities. The disclosure aligns with standard reporting obligations for officer/director dispositions.

Timing and cash-flow treatment beyond the per-transaction dollar lines are not expanded in the excerpt; further filings may clarify remaining holdings and any tax-withholding mechanics.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales did SERA insider Robert Harrison report?

He reported specific sales on five dates totaling multiple dispositions. The filing lists sales on 12/30/2025, 01/27/2026, 02/24/2026, 03/09/2026, and 03/11/2026. Each line shows the share count and a corresponding dollar amount in the excerpt.

Were any of Robert Harrison's sales made under a 10b5-1 plan?

Yes. Several dispositions are labeled as 10b5-1 Sales in the excerpt. Those labeled entries include 12/30/2025, 01/27/2026, 02/24/2026, and others shown, indicating pre-arranged plan sales as disclosed.

Does the filing show restricted awards for SERA's insider?

The excerpt lists 2,000 Restricted Stock Units dated 02/06/2024 under securities to be sold. The entry identifies the instrument as Restricted Stock Units and ties the 2,000-unit figure to that date in the excerpt.

Do the sale lines in the filing show proceeds received?

Each transaction row pairs a share count with a dollar figure in the excerpt, e.g., 716 shares with 1460.64. Those dollar entries appear alongside the share counts as reported values in the Form 144 excerpt.

Is there any indication of post-sale holdings in this excerpt?

The provided excerpt does not state post-transaction holdings. It lists only the sale dates, share counts, and dollar figures; remaining ownership levels are not shown in the material provided.
Sera Prognostics, Inc.

NASDAQ:SERA

View SERA Stock Overview

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

70.82M
33.23M
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY